Contracts › 75F40125F19019
75F40125F19019: Support for Accelerating Rare Disease Cures (ARC) Program
Awarded to Eagle Hill Consulting, Llc by Food and Drug Administration (FDA).
$3.4Mobligated
$6.4Mpotential value
03 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40125F19019 |
|---|---|
| Vehicle | 75F40123A00010 |
| Awardee | Eagle Hill Consulting, Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 Administrative Management and General Management Consulting Services |
| PSC | R799 Support- Management: Other |
| Place of performance | MD |
| Period of performance | 01 August 2025 to 03 August 2027 |
| Potential end | 03 August 2029 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541611 contracts · All expiring contracts · USASpending record